MeiraGTx Holdings plc Deferred Tax Assets, Valuation Allowance
MeiraGTx Holdings plc (MGTX) had Deferred Tax Assets, Valuation Allowance of $174.81 million as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2026-03-30
- 2025-12-31: Deferred Tax Assets, Valuation Allowance $174.81M.
- 2024-12-31: Deferred Tax Assets, Valuation Allowance $149.38M.
- 2023-12-31: Deferred Tax Assets, Valuation Allowance $125.88M.
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $116.22M.
| Period end | Deferred Tax Assets, Valuation Allowance | Deferred Tax Assets, Valuation Allowance as first filed |
|---|---|---|
| 2025-12-31 | $174.81M 10-K · filed 2026-03-30 | |
| 2024-12-31 | $149.38M 10-K · filed 2026-03-30 | |
| 2023-12-31 | $125.88M 10-K · filed 2025-03-13 | |
| 2022-12-31 | $116.22M 10-K · filed 2024-03-15 | |
| 2021-12-31 | $90.27M 10-K · filed 2023-03-14 | |
| 2020-12-31 | $53.31M 10-K · filed 2022-03-10 | $53.31M 10-K · filed 2021-03-11 |
| 2019-12-31 | $37.52M 10-K · filed 2021-03-11 | |
| 2018-12-31 | $23.19M 10-K · filed 2020-03-11 | |
| 2017-12-31 | $10.70M 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |